Keyphrases
Idiopathic Pulmonary Fibrosis
100%
Vitamin K
100%
Comorbidity
28%
Matrix Gla Protein
28%
Lung Fibrosis
28%
Clinical Trials
14%
Increased Mortality
14%
Lung Cancer
14%
Antagonism
14%
High Prevalence
14%
Disease Progression
14%
Antifibrotic
14%
Anticoagulants
14%
Vitamin K Antagonists
14%
Coagulation Factors
14%
Expert Commentary
14%
Vitamin K Status
14%
Vascular Calcification
14%
Coagulation Cascade
14%
Deceleration
14%
Protein Activation
14%
Soft Tissue Calcification
14%
Stall
14%
Fibrosis Progression
14%
Area Cover
14%
Mitigating Effect
14%
INIS
patients
100%
fibrosis
100%
vitamin k
100%
lungs
30%
proteins
30%
matrices
20%
mortality
20%
morbidity
20%
administration
20%
diseases
10%
cancer
10%
tissues
10%
drugs
10%
modulation
10%
clinical trials
10%
interventions
10%
pathogenesis
10%
hypothesis
10%
acceleration
10%
anticoagulants
10%
deceleration
10%
shortfalls
10%
Pharmacology, Toxicology and Pharmaceutical Science
Vitamin K Group
100%
Fibrosing Alveolitis
100%
Osteocalcin
25%
Lung Fibrosis
25%
Comorbidity
25%
Prevalence
12%
Lung Cancer
12%
Anticoagulant Agent
12%
Antivitamin K
12%
Clinical Trial
12%
Disease Exacerbation
12%
Blood Clotting Factor
12%
Blood Vessel Calcification
12%
Fibrosis
12%
Soft Tissue Calcification
12%
Medicine and Dentistry
Idiopathic Pulmonary Fibrosis
100%
Pulmonary Fibrosis
28%
Comorbidity
28%
Matrix Gla Protein
28%
Prevalence
14%
Lung Cancer
14%
Clinical Trial
14%
Fibrosis
14%
Blood Clotting Factor
14%
Blood Vessel Calcification
14%
Disease Exacerbation
14%
Vitamin K Antagonist
14%
Anticoagulant
14%
Soft Tissue Calcification
14%